Common Stock, Shares, Outstanding of Seres Therapeutics, Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Seres Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • Seres Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 9,556,446, a 10% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Seres Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 9,556,446 +906,219 +10% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q3 2025 8,764,664 -161,435,589 -95% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 8,754,482 -142,879,440 -94% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 8,732,187 -142,709,847 -94% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 8,650,227 -126,391,240 -94% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q3 2024 170,200,253 +41,569,564 +32% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 151,633,922 +23,596,243 +18% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 151,442,034 +24,849,430 +20% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 135,041,467 +9,819,194 +7.8% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 128,630,689 +4,219,772 +3.4% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 128,037,679 +35,730,735 +39% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 126,592,604 +34,382,299 +37% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 125,222,273 +33,332,855 +36% 31 Dec 2022 8-K 15 Aug 2024
Q3 2022 124,410,917 +32,568,943 +35% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 92,306,944 +593,134 +0.65% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 92,210,305 +622,041 +0.68% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 91,889,418 +430,179 +0.47% 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q3 2021 91,841,974 +627,438 +0.69% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 91,713,810 +16,581,976 +22% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 91,588,264 +19,917,197 +28% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 91,459,239 +21,315,987 +30% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 91,214,536 +21,220,584 +30% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 75,131,834 +5,218,424 +7.5% 30 Jun 2020 10-Q 28 Jul 2020 2020 Q2
Q1 2020 71,671,067 +30,576,235 +74% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 70,143,252 +29,206,517 +71% 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q3 2019 69,993,952 +29,149,497 +71% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 69,913,410 +29,158,729 +72% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 41,094,832 +442,164 +1.1% 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 40,936,735 +365,720 +0.9% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 40,844,455 +331,816 +0.82% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 40,754,681 +342,646 +0.85% 30 Jun 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 40,652,668 +265,790 +0.66% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 40,571,015 +215,262 +0.53% 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 40,512,639 +156,886 +0.39% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 40,412,035 +552,880 +1.4% 30 Jun 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 40,386,878 +1,168,176 +3% 31 Mar 2017 10-Q 04 May 2017 2017 Q1
Q4 2016 40,355,753 +1,273,736 +3.3% 31 Dec 2016 10-K 08 Mar 2018 2017 FY
Q3 2016 40,355,753 +1,299,986 +3.3% 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 39,859,155 +9,442,528 +31% 30 Jun 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 39,218,702 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 39,082,017 +32,191,767 +467% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q3 2015 39,055,767 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 30,416,627 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q4 2014 6,890,250 31 Dec 2014 10-K 14 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.